Keywords: sb, requip, launched, usa, smithkline, beecham, its

SB's ReQuip Launched In USA

Article | 30 October 1997

Print This

SmithKline Beecham has launched its non-ergoline dopamine D2 agonist,ReQuip (ropinirole) in the USA for the treatment of the signs ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in